DGAP-News
Alphaform AG: Thomas Kresser joins Alphaform as Chief Financial Officer
DGAP-News: Alphaform AG / Key word(s): Change of Personnel
Alphaform AG: Thomas Kresser joins Alphaform as Chief Financial
Officer
15.09.2014 / 21:10
---------------------------------------------------------------------
Press release
Thomas Kresser joins Alphaform as Chief Financial Officer
Feldkirchen, 15 September 2014 - With effect from 1 October, Alphaform AG,
a service provider for industrial 3D printing, is appointing Thomas Kresser
(55) to its Management Board. He will manage the company as Chief Financial
Officer alongside CEO Dr Hanns-Dieter Aberle. Kresser has more than 15
years of management experience as General Manager and CFO. He is at home in
business with both consumer goods and industrial customers and has
extensive experience in turnaround and restructuring projects, M&A,
integrations, and growth strategies. Kresser has worked abroad for over ten
years in total and has held CFO posts in the USA, Portugal and Switzerland.
Most recently, he was Chief Financial Officer and member of the Board at
Alstom Deutschland AG.
"We are delighted to have obtained such an experienced manager to fill the
CFO post," said the Supervisory Board Chairman of Alphaform AG, Matti
Paasila. "His seniority and his extraordinarily broad field of vision make
him a first-class choice for Alphaform."
About Alphaform
Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term "3D printing". An important mainstay of the segment 3D
Printing an Additive Manufacturing ist the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Devision of Alphaform has al leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of alphaform are listed in the Prime Standard Segment of the
Frankfurt Stock Exchange (FWB) under the abbreviation ATF.
The core competence of Alphaform lies in its extensive application know how
for processes and materials for additive production of complex prototypes,
tools, individual components and small series made of plastic and metal.
The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Hanns-Dieter Aberle, CEO
ALPHAFORM AG
Kapellenstraße 10
85622 Feldkirchen
Tel.: +49 89 905002 35
Thomas Kresser joins Alphaform as Chief Financial Officer
Feldkirchen, 15 September 2014 - With effect from 1 October, Alphaform AG,
a service provider for industrial 3D printing, is appointing Thomas Kresser
(55) to its Management Board. He will manage the company as Chief Financial
Officer alongside CEO Dr Hanns-Dieter Aberle. Kresser has more than 15
years of management experience as General Manager and CFO. He is at home in
business with both consumer goods and industrial customers and has
extensive experience in turnaround and restructuring projects, M&A,
integrations, and growth strategies. Kresser has worked abroad for over ten
years in total and has held CFO posts in the USA, Portugal and Switzerland.
Most recently, he was Chief Financial Officer and member of the Board at
Alstom Deutschland AG.
"We are delighted to have obtained such an experienced manager to fill the
CFO post," said the Supervisory Board Chairman of Alphaform AG, Matti
Paasila. "His seniority and his extraordinarily broad field of vision make
him a first-class choice for Alphaform."
About Alphaform
Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term "3D printing". An important mainstay of the segment 3D
Printing an Additive Manufacturing ist the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Devision of Alphaform has al leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of alphaform are listed in the Prime Standard Segment of the
Frankfurt Stock Exchange (FWB) under the abbreviation ATF.
The core competence of Alphaform lies in its extensive application know how
for processes and materials for additive production of complex prototypes,
tools, individual components and small series made of plastic and metal.
The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Hanns-Dieter Aberle, CEO
ALPHAFORM AG
Kapellenstraße 10
85622 Feldkirchen
Tel.: +49 89 905002 35
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte